News | Coronavirus (COVID-19) | August 04, 2020

The CORAL Study will help researchers describe the clinical characteristics, treatments, biology, and outcomes of hospitalized patients with COVID-19

The CORAL Study will help researchers describe the clinical characteristics, treatments, biology, and outcomes of hospitalized patients with COVID-19

Getty Images


August 4, 2020 — The American College of Radiology (ACR) Center for Research and Innovation (CRI) will serve as the imaging coordination center for the multicenter COVID-19 Observational Study (CORAL) led by Catherine "Terri" L. Hough, M.D., of the Oregon Health & Science University. The CORAL Study is part of the Prevention & Early Treatment of Acute Lung Injury (PETAL) Network, a consortium of academic and affiliated hospitals across the United States – funded by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health – to conduct clinical trials in patients with or at risk for critical illness, including acute respiratory distress syndrome.

The purpose of CORAL is to inform epidemiology and resource utilization through three interrelated approaches: a registry; a detailed cohort, including a bio-specimen collection correlated with clinical phenotyping and outcomes; and a health system assessment. In collaboration with CORAL leadership, and following standards developed for this study, the ACR CRI will collect imaging exams on registry subjects, create a link between the images and clinical data collected by PETAL, archive images throughout study duration and, once complete, make images accessible to researchers.

At present, little is known about the epidemiology of novel coronavirus (COVID-19) in the United States. Rapid expansion of cases across this country and others necessitates urgent study of severe acute COVID-19 in order to care for patients, inform and develop treatments, target therapeutics, prognosticate and understand health system impacts. The CORAL Study is a responsive effort to these needs.

“We at the ACR are pleased and proud to be part of the effort by our colleagues who are caring for patients suffering with COVID-19 who require hospital care. We hope the collection of imaging and clinical data that the PETAL project creates will lead to improved treatment and diagnosis of COVID-19 complications, including advanced lung disease, stroke and cardiac dysfunction,” said Etta Pisano, M.D., chief research officer of the ACR.

Learn more about CORAL and opportunities for collaboration.

Learn more about PETAL Network.


Related Content

News | X-Ray

Dec. 1, 2025 – Zwanger-Pesiri Radiology, one of the most respected and technologically advanced outpatient radiology ...

Time December 03, 2025
arrow
News | Interventional Radiology

Dec. 1, 2025 — GE HealthCare has unveiled the Allia Moveo,1 an image guiding solution designed to enhance mobility and ...

Time December 02, 2025
arrow
News | Archive Cloud Storage

Nov. 30, 2025 — Gradient Health, Inc. has released Atlas 2, a major upgrade to its self-service medical imaging data ...

Time December 01, 2025
arrow
News | Artificial Intelligence

Nov. 24, 2025 — Siemens Healthineers is launching artificial intelligence-enabled services to help healthcare providers ...

Time November 24, 2025
arrow
News | Artificial Intelligence

Nov. 20, 2025 — Aidoc has announced a collaboration with AdventHealth to launch one of the largest imaging AI ...

Time November 21, 2025
arrow
News | Radiology Business

Nov. 13, 2025 — Covera Health recently announced that Advanced Radiology Services (ARS) has joined its national Quality ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Orthopedic Imaging

Nov.10, 2025 — Medical imaging technology company Adaptix Ltd. has received 510(k) clearance from the U.S. Food and Drug ...

Time November 11, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Nov. 10, 2025 — There has been substantial progress in the past few years in the field of MRI in general and remote MR ...

Time November 11, 2025
arrow
News | Contrast Media

Nov. 10, 2025 — Scientists at the University of Birmingham have developed a new class of MRI contrast agents – improving ...

Time November 10, 2025
arrow
Subscribe Now